Stay updated with breaking news from Ming Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Ambarella, Inc. (NASDAQ:AMBA – Get Rating) have received a consensus rating of “Moderate Buy” from the seventeen ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have issued a buy recommendation on the […]
/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today...
Ambarella, Inc. (NASDAQ:AMBA – Get Rating) CEO Feng-Ming Wang sold 3,937 shares of the stock in a transaction on Thursday, June 16th. The shares were sold at an average price of $66.26, for a total transaction of $260,865.62. Following the transaction, the chief executive officer now owns 689,918 shares of the company’s stock, valued at […]
Chien-Ming Wang’s foot injury in June 2008 brought his Yankees career to a screeching halt
Ambarella (NASDAQ:AMBA – Get Rating) had its price objective cut by equities researchers at Wells Fargo & Company from $125.00 to $110.00 in a research report issued to clients and investors on Wednesday, The Fly reports. Wells Fargo & Company‘s price objective suggests a potential upside of 29.08% from the company’s previous close. Several other […]